NuVasive Inks $14M FCA Deal Over Kickbacks, Off-Label Uses
By Jeff Overley · July 30, 2015, 4:50 PM EDT
Medical device maker NuVasive Inc. will pay $13.5 million to resolve whistleblower allegations that it violated the False Claims Act by promoting off-label uses of spinal fusion products for Medicare patients...
To view the full article, register now.